Fundación Jiménez Díaz -ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2024

  1. Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real-world data study

    European Journal of Neurology

  2. The association between lifestyle factors and mortality in Huntington's disease

    Neurologia

2023

  1. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

    Neurologia, Vol. 38, Núm. 5, pp. 326-333

2022

  1. Polyunsaturated Fatty Acid-Enriched Lipid Fingerprint of Glioblastoma Proliferative Regions Is Differentially Regulated According to Glioblastoma Molecular Subtype

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

2021

  1. Influence of Genetic Polymorphisms on the Response to Tramadol, Ibuprofen, and the Combination in Patients With Moderate to Severe Pain After Dental Surgery

    Clinical Therapeutics, Vol. 43, Núm. 5, pp. e86-e102

2019

  1. Clinical and genetic characteristics of late-onset Huntington's disease

    Parkinsonism and Related Disorders, Vol. 61, pp. 101-105

2018

  1. Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers

    Basic and Clinical Pharmacology and Toxicology, Vol. 122, Núm. 6, pp. 596-605

  2. Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

    Journal of Huntington's Disease, Vol. 7, Núm. 3, pp. 209-222

2017

  1. Cognitive decline in Huntington's disease expansion gene carriers

    Cortex, Vol. 95, pp. 51-62

2016

  1. Factors Associated with Low Body Mass Index in Huntington's Disease: A Spanish Multicenter Study of the European Huntington's Disease Registry

    Movement Disorders Clinical Practice, Vol. 3, Núm. 5, pp. 452-459

  2. Factors associated with Mediterranean diet adherence in Huntington's disease

    Clinical Nutrition ESPEN, Vol. 12, pp. e7-e13

2013

  1. Suicidal ideation in a European Huntington's disease population

    Journal of Affective Disorders, Vol. 151, Núm. 1, pp. 248-258

  2. The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients

    PLoS ONE, Vol. 8, Núm. 7

  3. β-defensin genomic copy number does not influence the age of onset in huntington’s disease

    Journal of Huntington's Disease, Vol. 2, Núm. 1, pp. 107-124

2012

  1. Discrepancies in reporting the CAG repeat lengths for Huntington’s disease

    European Journal of Human Genetics, Vol. 20, Núm. 1, pp. 20-26

2011

  1. NMDA receptor gene variations as modifiers in Huntington disease: A replication study

    PLoS Currents

2009

  1. Rasch analysis of the Hospital Anxiety and Depression scale in Parkinson's disease

    Movement Disorders, Vol. 24, Núm. 4, pp. 526-532

2006

  1. Creación y protocolo de seguimiento longitudinal de una cohorte multipropósito de pacientes con enfermedad de Parkinson de reciente diagnóstico: Proyecto VIP

    Revista de Neurologia, Vol. 43, Núm. 6, pp. 366-373

2005

  1. Transcultural comparison of psychogenic movement disorders

    Movement Disorders, Vol. 20, Núm. 10, pp. 1343-1345

2004

  1. Bloqueo (freezing) del gateo o bloqueo de la marcha cuadrúpeda

    Neurologia, Vol. 19, Núm. 2, pp. 77-79